Viewing Study NCT03990961


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-01-22 @ 6:58 PM
Study NCT ID: NCT03990961
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2019-06-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module